CSL, Limited

Organization

Victoria, AU

Business Address
45 POPLAR ROAD PARKVILLE C3 VIC3052
State Location
C3
State of Incorporation

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods of administering inhibitory anti-factor XII/XIIa monoclonal...
- Patent number 11,345,759
- Issue date May 31, 2022
- CSL Behring GmbH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor XII inhibitors for the treatment of neurological inflammator...
- Patent number 9,957,329
- Issue date May 1, 2018
- CSL Behring GmbH
- Sven Meuth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent complex of von Willebrand Factor and factor VIII, composit...
- Patent number 9,878,017
- Issue date Jan 30, 2018
- CSL Ltd.
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal a...
- Patent number 9,856,325
- Issue date Jan 2, 2018
- CSL Behring GmbH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering inhibitory anti-factor XII/XIIA monoclonal...
- Patent number 9,856,326
- Issue date Jan 2, 2018
- CSL Behring GmbH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses
- Patent number 9,518,127
- Issue date Dec 13, 2016
- CSL Behring GmbH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immune response targeting molecules
- Patent number 7,423,016
- Issue date Sep 9, 2008
- CSL, Limited
- Jeffrey Stephen Boyle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Enhancement of immune response using targeting molecules
- Patent number 7,423,023
- Issue date Sep 9, 2008
- CSL, Limited
- Jeffrey Stephen Boyle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antigenic preparation for treatment or prevention of helicobacter i...
- Patent number 6,663,873
- Issue date Dec 16, 2003
- CSL
- Christopher Vincent Doidge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD
- Publication number 20200247903
- Publication date Aug 6, 2020
- CSL LTD.
- Alan Lazarus
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF ADMINISTERING INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL...
- Publication number 20200062863
- Publication date Feb 27, 2020
- CSL BEHRING GMBH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF ADMINISTERING INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL...
- Publication number 20180134806
- Publication date May 17, 2018
- CSL BEHRING GMBH
- Con Panousis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES
- Publication number 20170137536
- Publication date May 18, 2017
- CSL BEHRING GMBH
- Con Panousis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES
- Publication number 20170121423
- Publication date May 4, 2017
- CSL BEHRING GMBH
- Con Panousis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
75550812 - SPIROVAC
- Serial number 75550812
- Registration number 2705667
- Filing date Sep 10, 1998
- CSL LIMITED (AUSTRALIA, CORPORATION)
- 5 - Pharmaceutical and veterinary preparations

CSL, Limited

Organization

Business Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Methods of administering inhibitory anti-factor XII/XIIa monoclonal...

Factor XII inhibitors for the treatment of neurological inflammator...

Covalent complex of von Willebrand Factor and factor VIII, composit...

Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal a...

Methods of administering inhibitory anti-factor XII/XIIA monoclonal...

Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses

Immune response targeting molecules

Enhancement of immune response using targeting molecules

Antigenic preparation for treatment or prevention of helicobacter i...

Patents Applicationslast 30 patents

METHOD

METHODS OF ADMINISTERING INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL...

METHODS OF ADMINISTERING INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL...

INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES

INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES

Trademarklast 30 trademarks

75550812 - SPIROVAC